These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 38102698

  • 1. CSF-1R inhibitor PLX3397 attenuates peripheral and brain chronic GVHD and improves functional outcomes in mice.
    Shaikh SN, Willis EF, Dierich M, Xu Y, Stuart SJS, Gobe GC, Bashaw AA, Rawashdeh O, Kim SJ, Vukovic J.
    J Neuroinflammation; 2023 Dec 15; 20(1):300. PubMed ID: 38102698
    [Abstract] [Full Text] [Related]

  • 2. CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease.
    Alexander KA, Flynn R, Lineburg KE, Kuns RD, Teal BE, Olver SD, Lor M, Raffelt NC, Koyama M, Leveque L, Le Texier L, Melino M, Markey KA, Varelias A, Engwerda C, Serody JS, Janela B, Ginhoux F, Clouston AD, Blazar BR, Hill GR, MacDonald KP.
    J Clin Invest; 2014 Oct 15; 124(10):4266-80. PubMed ID: 25157821
    [Abstract] [Full Text] [Related]

  • 3. CSF1R inhibition promotes neuroinflammation and behavioral deficits during graft-versus-host disease in mice.
    Adams RC, Carter-Cusack D, Llanes GT, Hunter CR, Vinnakota JM, Ruitenberg MJ, Vukovic J, Bertolino P, Chand KK, Wixey JA, Nayler SP, Hill GR, Furlan SN, Zeiser R, MacDonald KPA.
    Blood; 2024 Mar 07; 143(10):912-929. PubMed ID: 38048572
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. B cells in chronic graft-versus-host disease.
    McManigle W, Youssef A, Sarantopoulos S.
    Hum Immunol; 2019 Jun 07; 80(6):393-399. PubMed ID: 30849450
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Donor bone marrow-derived macrophage MHC II drives neuroinflammation and altered behavior during chronic GVHD in mice.
    Adams RC, Carter-Cusack D, Shaikh SN, Llanes GT, Johnston RL, Quaife-Ryan G, Boyle G, Koufariotis LT, Möller A, Blazar BR, Vukovic J, MacDonald KPA.
    Blood; 2022 Mar 03; 139(9):1389-1408. PubMed ID: 34570880
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of secondary engraftment failure with granulocyte colony-stimulating factor and eltrombopag after allogeneic peripheral blood stem cell transplantation in adult T-cell leukemia/lymphoma].
    Kiyohara K, Sugawara N, Maeta T, Miyajima S, Takano M, Nishiya M, Nishiya M, Sasaki R, Okano Y, Kamihara S, Kowata S, Oyake T, Ito S.
    Rinsho Ketsueki; 2021 Mar 03; 62(10):1499-1504. PubMed ID: 34732623
    [Abstract] [Full Text] [Related]

  • 13. Positive Effects of Oral Antibiotic Administration in Murine Chronic Graft-Versus-Host Disease.
    Sato S, Shimizu E, He J, Ogawa M, Asai K, Yazu H, Rusch R, Yamane M, Yang F, Fukuda S, Kawakami Y, Tsubota K, Ogawa Y.
    Int J Mol Sci; 2021 Apr 03; 22(7):. PubMed ID: 33916809
    [Abstract] [Full Text] [Related]

  • 14. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
    Grube M, Holler E, Weber D, Holler B, Herr W, Wolff D.
    Biol Blood Marrow Transplant; 2016 Oct 03; 22(10):1781-1791. PubMed ID: 27343720
    [Abstract] [Full Text] [Related]

  • 15. Targeting Bcl-6 prevents sclerodermatous chronic graft-versus-host disease by abrogating T follicular helper differentiation in mice.
    Chen X, Wang Y, Huang X, Geng S, Li C, Zeng L, Huang L, Du X, Weng J, Lai P.
    Int Immunopharmacol; 2023 Apr 03; 117():109746. PubMed ID: 36827923
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. GM-CSF therapy inhibits chronic graft-versus-host disease via expansion of regulatory T cells.
    Hotta M, Yoshimura H, Satake A, Tsubokura Y, Ito T, Nomura S.
    Eur J Immunol; 2019 Jan 03; 49(1):179-191. PubMed ID: 30457669
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.